ArticleExperimental and therapeutic medicine2025
Totally endoscopic trans‑superior articular process lumbar interbody fusion: A case series on the development and preliminary evaluation of an innovative minimally invasive lumbar spine surgical technique.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study is a retrospective analysis aimed at evaluating the early clinical efficacy and preliminary safety of full-endoscopic transforaminal upper facet joint lumbar interbody fusion (TSAP-LIF) in patients with lumbar degenerative diseases treated at the Department of Orthopaedics at Changzhi Yunfeng Hospital (Changzhi, China). The present study collected clinical follow-up data and radiological images, which were accessed and collected between January 1, 2021 and December 31, 2022. All surgeries were performed by the same group of experienced surgeons to ensure consistency in surgical technique and its impact on patient outcomes. The study included patients' preoperative baseline characteristics, operative time, intraoperative blood loss, postoperative complications and follow-up results (with a follow-up period of 6 months). Clinical outcomes were assessed using the Oswestry Disability Index (ODI) and Visual Analog Scale (VAS), and radiological evaluations were conducted using postoperative X-rays and computed tomography scans to determine the intervertebral fusion rate. Among the 9 patients, there were 4 men and 5 women, with an average age of 47.3±13.1 years (range, 23-67 years). The average operation time was 113.3±13.9 min, and the average intraoperative blood loss was 101.6±13.8 ml. The postoperative complication rate was 0%. The average hospital stay was 12.7±3.2 days. The average VAS score improved from 7.7±1.4 preoperatively to 2.6±1.2 at 3 months postoperatively and to 1.2±1.1 at 6 months postoperatively. The average ODI score improved from 56.7±8.2 preoperatively to 22.7±5.6 at 1 month postoperatively and to 10.2±4.2 at 6 months postoperatively. Radiological examinations showed an intervertebral fusion rate of 88% at 6 months postoperatively. Retrospective analysis indicates that TSAP-LIF is a safe and effective method for treating lumbar degenerative diseases. The clinical outcomes are significant, with reduced operation time, marked improvement in patient pain and function and a high intervertebral fusion rate. To further evaluate the clinical efficacy of this procedure, larger sample sizes and longer follow-up periods are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.